Your browser doesn't support javascript.
loading
Failure of Healthcare Provision for Attention-Deficit/Hyperactivity Disorder in the United Kingdom: A Consensus Statement.
Young, Susan; Asherson, Philip; Lloyd, Tony; Absoud, Michael; Arif, Muhammad; Colley, William Andrew; Cortese, Samuele; Cubbin, Sally; Doyle, Nancy; Morua, Susan Dunn; Ferreira-Lay, Philip; Gudjonsson, Gisli; Ivens, Valerie; Jarvis, Christine; Lewis, Alexandra; Mason, Peter; Newlove-Delgado, Tamsin; Pitts, Mark; Read, Helen; van Rensburg, Kobus; Zoritch, Bozhena; Skirrow, Caroline.
Afiliación
  • Young S; Psychology Services Limited, London, United Kingdom.
  • Asherson P; Department of Psychology, Reykjavik University, Reykjavik, Iceland.
  • Lloyd T; ADHD Foundation, Liverpool, United Kingdom.
  • Absoud M; Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, United Kingdom.
  • Arif M; South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Colley WA; ADHD Foundation, Liverpool, United Kingdom.
  • Cortese S; Department of Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Cubbin S; King's Health Partners Academic Health Science Centre, London, United Kingdom.
  • Doyle N; Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Morua SD; Leicestershire Partnership NHS Trust, Leicester, United Kingdom.
  • Ferreira-Lay P; CLC Consultancy, Perth, United Kingdom.
  • Gudjonsson G; SWB (Global), Glasgow, United Kingdom.
  • Ivens V; Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences & Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
  • Jarvis C; Solent NHS Trust, Southampton, United Kingdom.
  • Lewis A; Division of Psychiatry and Applied Psychology, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • Mason P; Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York, NY, United States.
  • Newlove-Delgado T; The ADHD Clinic, Manor Hospital, Oxford, United Kingdom.
  • Pitts M; Genius Within, Plumpton Green, United Kingdom.
  • Read H; Department of Organizational Psychology, Birkbeck College, University of London, London, United Kingdom.
  • van Rensburg K; AADD-United Kingdom, Bristol, United Kingdom.
  • Zoritch B; Bristol Adult ADHD Support Group, Bristol, United Kingdom.
  • Skirrow C; Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, United Kingdom.
Front Psychiatry ; 12: 649399, 2021.
Article en En | MEDLINE | ID: mdl-33815178
Background: Despite evidence-based national guidelines for ADHD in the United Kingdom (UK), ADHD is under-identified, under-diagnosed, and under-treated. Many seeking help for ADHD face prejudice, long waiting lists, and patchy or unavailable services, and are turning to service-user support groups and/or private healthcare for help. Methods: A group of UK experts representing clinical and healthcare providers from public and private healthcare, academia, ADHD patient groups, educational, and occupational specialists, met to discuss shortfalls in ADHD service provision in the UK. Discussions explored causes of under-diagnosis, examined biases operating across referral, diagnosis and treatment, together with recommendations for resolving these matters. Results: Cultural and structural barriers operate at all levels of the healthcare system, resulting in a de-prioritization of ADHD. Services for ADHD are insufficient in many regions, and problems with service provision have intensified as a result of the response to the COVID-19 pandemic. Research has established a range of adverse outcomes of untreated ADHD, and associated long-term personal, social, health and economic costs are high. The consensus group called for training of professionals who come into contact with people with ADHD, increased funding, commissioning and monitoring to improve service provision, and streamlined communication between health services to support better outcomes for people with ADHD. Conclusions: Evidence-based national clinical guidelines for ADHD are not being met. People with ADHD should have access to healthcare free from discrimination, and in line with their legal rights. UK Governments and clinical and regulatory bodies must act urgently on this important public health issue.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Qualitative_research Idioma: En Revista: Front Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Qualitative_research Idioma: En Revista: Front Psychiatry Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza